Biopharma Credit PLC
Records under this name other than patents Biopharma Credit PLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,406,870 | Treating Cancer Using Electromagnetic Fields in Combination with Other Treatment Regimens Formerly held In force · High confidence | In force | High confidence | |
| US 7,851,143 | Assays for Diagnosing and Evaluating Treatment Options for Fabry Disease Formerly held In force · High confidence | In force | High confidence | |
| US 9,000,011 | Methods For Treatment of Fabry Disease Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,480,682 | Methods for Treatment of Fabry Disease Formerly held In force · Low confidence | In force | Low confidence | |
| US 9,987,263 | Methods for Treatment of Fabry Disease Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,383,864 | Methods for Treatment of Fabry Disease Formerly held In force · Low confidence | In force | Low confidence | |
| US 10,406,143 | Methods for Treatment of Fabry Disease Formerly held In force (reinstated) · Low confidence | In force (reinstated) | Low confidence | |
| US 11,241,422 | Methods for Treatment of Fabry Disease Formerly held In force · Low confidence | In force | Low confidence | |
| US 8,147,866 | Transmucosal Delivery Devices with Enhanced Uptake Formerly held In force · High confidence | In force | High confidence | |
| US 9,655,843 | Transmucosal Delivery Devices with Enhanced Uptake Formerly held In force · Medium confidence | In force | Medium confidence |